Identifying Predictors of Poor Health-Related Quality-of-Life Among Pediatric Hematopoietic Stem Cell Donors

Recruiting at30 trial locations

Overseen by Galen Switzer, Ph.D

Age: Any Age

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Center for International Blood and Marrow Transplant Research

No Placebo Group

Trial Summary

What is the purpose of this trial?

To compare donors to their non-donor counterparts and healthy controls as well as to generate trajectory classes based on longitudinal patterns of donor HRQoL and identify predictors of poor donor HRQoL.

Research Team

Galen Switzer, Ph.D

Principal Investigator

University of Pittsburgh

Eligibility Criteria

Inclusion Criteria

Parent/caregiver of study participating donor Recipient sibling aged 5 to 17 of study participating donor Any of the donor's non-donor/non-recipient siblings between 5 and 17

Any child between 5 and 17 with a brother or sister (also between 5 and 17) receiving a transplant from an unrelated source

Adults must give consent for their children's and, if applicable, their own participation

Treatment Details

Interventions

• N/A (N/A)

Who Is Running the Clinical Trial?

Center for International Blood and Marrow Transplant Research

Lead Sponsor

Trials

40

Recruited

200,190,000+

University of Pittsburgh

Collaborator

Trials

1,820

Recruited

16,360,000+

David Apelian

University of Pittsburgh

Chief Executive Officer since 2019

PhD in Molecular Biology from Rutgers University, MD from the University of Medicine and Dentistry of New Jersey, MBA from Quinnipiac University

Pamela D. Garzone

University of Pittsburgh

Chief Medical Officer

PhD in Clinical Science from the University of Pittsburgh